Clinical Trial Update: Study of SHR-8068 Combined With Adebrelimab and Bevacizumab in the Treatment of Advanced Hepatocellular Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating SHR-8068 combined with Adebrelimab and Bevacizumab for advanced hepatocellular carcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Adebrelimab (adebrelimab)
• Bevacizumab (bevacizumab)
• SHR-8068

Snippet

Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Conditions: Advanced Hepatocellular Carcinoma | Phase 1, Phase 2 | Status: RECRUITING